Swedencare Ab · OMXSTO:SECARE
Swedencare Ab — Q4 2022 Earnings Presentation
12 slides from Swedencare Ab's earnings presentation, December 2022
Slide 1: Q4 Year End Report September - December 2022
Q4 YEAR END REPORT September - December 2022 Presentation CEO Håkan Lagerberg CFO Jenny Graflind
Slide 2: Q4 2022 Highlights
Q4 2022 Highlights A strong quarter despite challenges Sales record, profitability and cash flow up but disappointing growth Organic growth -5% Record quarters for several of our smaller group companies Ongoing major agreements impacted sales Acquisition of Custom Vet Products
Slide 3: Market outlook
Market outlook Continued growth number of pets in both US and Europe in 2022 (3-5%) Average spend continue to rise Food, supplements and treats grow More players target generica market
Slide 4: Net sales and Operational EBITDA (MSEK)
Operational EBITDA Net sales (MSEK) (MSEK) 600 140 500 120 400 100 9 5% 9% 14 80 300 497,4 60 24,1% 200 40 255,2 18,9% 100 20 0 - Q4 2021 Q4 2022 Q4 2021 Q4 2022
Slide 5: Key Performance Indicators Q4 2022
Key Performance Indicators Q4 2022
Slide 6: Net Sales by region (MSEK) – 80% of total
Net Sales by region (MSEK) – 80% of total North America • Wide differences among group companies in 450 growth 400 • Vetio South weak but not due to customer demand, complexity, some staffing and supply 350 issues –Action plan in place, Q1 will be at least 30% 300 10 6% stronger in sales, strong lis
Slide 7: Net Sales by region (MSEK) – 18% of total
Net Sales by region (MSEK) – 18% of total • Strong quarterly growth Europe • Sales still affected negatively by inventory 100 adjustment for Nutravet, however strong sales 90 from newly started D2C webshop, Chris Jones, 80 former COO took over as new MD as of 1 Jan 70 84 % • Swedencare UK and Spain,
Slide 8: Net Sales by region (MSEK) – 2% of total
Net Sales by region (MSEK) – 2% of total Rest of the world 16 • Quarterly growth but down Y-Y due to China orders which are down 70% full year. However, distributor 14 has indicated that 2023 will be a strong come back -2 2 % 12 • South Korea, Australia, Poland, Switzerland among top 10 markets 8 •
Slide 9: Key Performance Indicators 2022
Key Performance Indicators 2022
Slide 10: Rolling 4 Quarters
Rolling 4 Quarters 1700 1600 1.500 1 400|. 1300. 1 200 1100 1.000 900 800 700 600 500 400 300 200 100 #8 SWEDENCARE
Slide 11: Priorities 2023/2024
Priorities 2023/2024 Growth and profitability and lowering debt level Deliver on strong pipeline Continued move from external to internal Product launches and development Solidifying relationships with major customers Co-op and M&A opportunities
Slide 12: Thank You for participating! Q&A
Thank You for participating! Q&A